Dr Gian P. Camenisch, Novartis Institute of Biomedical Research (NIBR), Basel
| Start Date | 21.11.2018 - 17:00 |
| Event End | 21.11.2018 - 18:00 |
| Location | Universität Basel, Pharmazentrum |
Assessing Class-Dependant Drug Development Risk using a novel Compound Categorization
Approach.